HOOKIPA PHARMA INC.: investing cash flow
Investing cash flow for HOOKIPA PHARMA INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All HOOKIPA PHARMA INC. financial histories
What this measure means
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
Exact concept: us-gaap:NetCashProvidedByUsedInInvestingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-01-01 | 2024-12-31 | -194,000 | USD | 2025-02-28 | 10-K · 0001558370-25-001853 |
| 2023-01-01 | 2023-12-31 | -4,159,000 | USD | 2025-02-28 | 10-K · 0001558370-25-001853 |
| 2022-01-01 | 2022-12-31 | -5,017,000 | USD | 2025-02-28 | 10-K · 0001558370-25-001853 |
| 2021-01-01 | 2021-12-31 | -12,581,000 | USD | 2024-03-22 | 10-K · 0001558370-24-003738 |
| 2020-01-01 | 2020-12-31 | -2,371,000 | USD | 2023-03-15 | 10-K · 0001558370-23-003778 |
| 2019-01-01 | 2019-12-31 | -1,999,000 | USD | 2022-03-24 | 10-K · 0001558370-22-004211 |
| 2018-01-01 | 2018-12-31 | -2,150,000 | USD | 2021-03-18 | 10-K · 0001558370-21-003176 |
| 2017-01-01 | 2017-12-31 | -1,297,000 | USD | 2020-03-19 | 10-K · 0001558370-20-002928 |
Related financial histories
- HOOKIPA PHARMA INC.: total assets
- HOOKIPA PHARMA INC.: total liabilities
- HOOKIPA PHARMA INC.: stockholders equity
- HOOKIPA PHARMA INC.: cash and cash equivalents
- HOOKIPA PHARMA INC.: net income or loss
- HOOKIPA PHARMA INC.: operating cash flow
- HOOKIPA PHARMA INC.: capital expenditure payments
- HOOKIPA PHARMA INC.: contract revenue excluding tax
- HOOKIPA PHARMA INC.: financing cash flow
- HOOKIPA PHARMA INC.: retained earnings or deficit
- HOOKIPA PHARMA INC.: basic weighted-average shares
- HOOKIPA PHARMA INC.: diluted weighted-average shares
- HOOKIPA PHARMA INC.: basic earnings per share
- HOOKIPA PHARMA INC.: diluted earnings per share
- HOOKIPA PHARMA INC.: income tax expense or benefit
- HOOKIPA PHARMA INC.: net property, plant and equipment
- HOOKIPA PHARMA INC.: share-based compensation expense
- HOOKIPA PHARMA INC.: operating income or loss
- HOOKIPA PHARMA INC.: current assets
- HOOKIPA PHARMA INC.: interest expense
- HOOKIPA PHARMA INC.: current liabilities
- HOOKIPA PHARMA INC.: current accounts payable
- HOOKIPA PHARMA INC.: net current accounts receivable
- HOOKIPA PHARMA INC.: research and development expense
Inspect the source
- Entity
- HOOKIPA PHARMA INC. / CIK 0001760542
- Captured
- 2026-09-21T17:26:23.041Z
- SEC response SHA-256
425733b21a8b5610e60365c7d0bb82cf6d837fb4ef2f55c5b1cb6e6e41084dba
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001760542.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))